Finepoint Capital »

Avidity Biosciences Ord shares owned by Finepoint Capital

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $11M 381k 29.52
2024-12-31 $11M 391k 29.08

More positions owned by Finepoint Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Qxo Com New (QXO)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Liberty Broadband Corp Com Ser C (LBRDK)
Springworks Therapeutics (SWTX)
Liberty Media Corp Del Com Lbty Liv S C (LLYVK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Revolution Medicines (RVMD)
MoonLake Immunotherapeutics Class A Ord (MLTX)
Galapagos Nv Spon Adr (GLPG)
Cytokinetics Com New (CYTK)
Avidity Biosciences Ord (RNA)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS (PRTA)
Xencor (XNCR)

View all positions for Finepoint Capital

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
BlackRock
Wellington Management Company
Vanguard Group
Rtw Investments
venBio Select Advisor
RA Capital Management
State Street Corporation
Geode Capital Management
Adage Capital Partners GP
Casdin Capital
OrbiMed Advisors
Driehaus Capital Management
Siren

View all funds holding Avidity Biosciences Ord